(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone

C58H96N10O11 — CID 170687274

IUPAC(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone
SMILESCC[C@H](C)[C@@H]1NC(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](Cc2ccccc2)CN(C)C(=O)CCN(C)C(=O)C[C@@H](C(=O)N2CCCCC2)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C1=O
InChIInChI=1S/C58H96N10O11/c1-16-39(8)50-58(79)67(15)46(31-38(6)7)56(77)66(14)44(29-36(2)3)52(73)59-43(55(76)68-26-21-18-22-27-68)33-49(72)62(10)28-25-48(71)63(11)34-42(32-41-23-19-17-20-24-41)54(75)65(13)45(30-37(4)5)53(74)61-51(40(9)69)57(78)64(12)35-47(70)60-50/h17,19-20,23-24,36-40,42-46,50-51,69H,16,18,21-22,25-35H2,1-15H3,(H,59,73)(H,60,70)(H,61,74)/t39-,40+,42+,43-,44-,45-,46-,50-,51-/m0/s1
InChIKeyDVQIAVOKDQODKO-SUIUQLCLSA-N
MW1109.46 g/mol
LogP2.53
Rot. Bonds12

About (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone

(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone (PubChem CID 170687274) has the molecular formula C58H96N10O11 and a molecular weight of 1109.46 g/mol. Its IUPAC name is (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone.

Molecular Properties

Compound Name(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone
PubChem CID170687274
Molecular FormulaC58H96N10O11
Molecular Weight1109.46 g/mol
Exact Mass1108.73
IUPAC Name(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone
SMILESCC[C@H](C)[C@@H]1NC(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](Cc2ccccc2)CN(C)C(=O)CCN(C)C(=O)C[C@@H](C(=O)N2CCCCC2)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C1=O
InChIInChI=1S/C58H96N10O11/c1-16-39(8)50-58(79)67(15)46(31-38(6)7)56(77)66(14)44(29-36(2)3)52(73)59-43(55(76)68-26-21-18-22-27-68)33-49(72)62(10)28-25-48(71)63(11)34-42(32-41-23-19-17-20-24-41)54(75)65(13)45(30-37(4)5)53(74)61-51(40(9)69)57(78)64(12)35-47(70)60-50/h17,19-20,23-24,36-40,42-46,50-51,69H,16,18,21-22,25-35H2,1-15H3,(H,59,73)(H,60,70)(H,61,74)/t39-,40+,42+,43-,44-,45-,46-,50-,51-/m0/s1
InChIKeyDVQIAVOKDQODKO-SUIUQLCLSA-N
XLogP2.53
TPSA249.70 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds12
Heavy Atoms79
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001109.46
LogP ≤ 52.53
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone?
The IUPAC name of (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone (CID 170687274) is (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone.
What is the SMILES notation for (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone?
The canonical SMILES for (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone is CC[C@H](C)[C@@H]1NC(=O)CN(C)C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](Cc2ccccc2)CN(C)C(=O)CCN(C)C(=O)C[C@@H](C(=O)N2CCCCC2)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C1=O.
What is the InChIKey of (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone?
The InChIKey is DVQIAVOKDQODKO-SUIUQLCLSA-N. The full InChI is InChI=1S/C58H96N10O11/c1-16-39(8)50-58(79)67(15)46(31-38(6)7)56(77)66(14)44(29-36(2)3)52(73)59-43(55(76)68-26-21-18-22-27-68)33-49(72)62(10)28-25-48(71)63(11)34-42(32-41-23-19-17-20-24-41)54(75)65(13)45(30-37(4)5)53(74)61-51(40(9)69)57(78)64(12)35-47(70)60-50/h17,19-20,23-24,36-40,42-46,50-51,69H,16,18,21-22,25-35H2,1-15H3,(H,59,73)(H,60,70)(H,61,74)/t39-,40+,42+,43-,44-,45-,46-,50-,51-/m0/s1.
What are the key properties of (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone?
(3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone has a molecular weight of 1109.46 g/mol, XLogP of 2.53, 12 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,15S,18S,21R,30S)-21-benzyl-9-[(2S)-butan-2-yl]-15-[(1R)-1-hydroxyethyl]-4,7,13,19,23,27-hexamethyl-3,6,18-tris(2-methylpropyl)-30-(piperidine-1-carbonyl)-1,4,7,10,13,16,19,23,27-nonazacyclotriacontane-2,5,8,11,14,17,20,24,28-nonone is sourced from PubChem (CID 170687274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).